The Journal of Organic Chemistry
Article
2.96 (s, 1.5H), 2.13 (s, 1.5H), 2.11 (s, 1.5H) ppm; 13C{1H} NMR
(100 MHz, CDCl3-d): δ 170.7, 170.4, 159.4, 159.2, 132.3, 131.2,
129.3, 128.8, 127.6, 127.5, 122.3, 121.3, 114.1, 113.9, 55.3, 55.2, 52.6,
49.3, 35.3, 33.4, 21.8, 21.3 ppm.
21.2 ppm. HRMS (ESITOF) m/z: [M + H]+ calcd for C13H15N2O,
215.1179; found, 215.1180.
(E)-N-(3-(3-methoxyphenyl)allyl)-N-methylacetamide (3na)9 was
obtained as pale-yellow oil (28.5 mg, 65%); purification by silica gel
1
(E)-N-(3-(2-chlorophenyl)allyl)-N-methylacetamide (3ga) was
obtained as pale-yellow oil (37.6 mg, 84%); purification by silica gel
chromatography (Rf = 0.23 eluent: PE/EA = 1:3); H NMR (400
MHz, CDCl3-d): δ 7.25−7.19 (m, 1H), 6.99−6.92 (m, 1H), 6.90 (s,
1H), 6.85−6.75 (m, 1H), 6.44 (dd, J = 15.6, 12.2 Hz, 1H), 6.19−6.06
(m, 1H), 4.14 (d, J = 6.4 Hz, 1H), 4.05 (d, J = 4.8 Hz, 1H), 3.81 (d, J
= 5.2 Hz, 3H), 2.98 (d, J = 2.8 Hz, 3H), 2.13 (d, J = 4.4 Hz, 3H)
ppm; 13C{1H} NMR (100 MHz, CDCl3-d): δ 170.8, 170.4, 159.8,
159.8, 138.0, 137.5, 132.6, 131.5, 129.6, 129.5, 124.9, 124.0, 119.0,
118.9, 113.6, 113.5, 111.7, 111.4, 55.2, 55.2, 52.5, 49.2, 35.4, 33.5,
21.8, 21.3 ppm.
1
chromatography (Rf = 0.25 eluent: PE/EA = 1:1); H NMR (400
MHz, CDCl3-d): δ 7.53−7.46 (m, 1H), 7.34 (t, J = 7.8 Hz, 1H),
7.27−7.12 (m, 2H), 6.86 (d, J = 15.8 Hz, 1H), 6.16−6.04 (m, 1H),
4.17 (d, J = 6.4 Hz, 1H), 4.08 (d, J = 5.6 Hz, 1H), 3.01 (s, 1.7H), 2.99
(s, 1.3H), 2.15 (s, 1.3H), 2.13 (s, 1.7H) ppm; 13C{1H} NMR (100
MHz, CDCl3-d): δ 170.7, 170.5, 134.7, 132.8, 129.7, 129.6, 128.9,
128.8, 128.6, 128.5, 127.5, 126.9, 126.9, 126.8, 126.7, 52.7, 49.3, 35.5,
33.4, 21.8, 21.3 ppm. HRMS (ESITOF) m/z: [M + H]+ calcd for
C12H15ClNO, 224.0837; found, 224.0839.
(E)-N-(3-(2-bromophenyl)allyl)-N-methylacetamide (3ha) was
obtained as pale-yellow oil (45.6 mg, 85%); purification by silica gel
chromatography (Rf = 21 eluent: PE/EA = 1:1); 1H NMR (400 MHz,
CDCl3-d): δ 7.57−7.42 (m, 2H), 7.25 (d, J = 10.0 Hz, 1H), 7.15−
7.03 (m, 1H), 6.80 (dd, J = 15.8, 4.4 Hz, 1H), 6.11−5.97 (m, 1H),
4.19−4.13 (m, 1H), 4.10−4.04 (m, 1H), 3.00 (s, 1.7H), 2.98 (s,
1.3H), 2.14 (s, 1.3H), 2.12 (s, 1.7H) ppm; 13C{1H} NMR (100 MHz,
CDCl3-d): δ 170.7, 170.5, 136.4, 136.2, 132.8, 132.8, 131.3, 131.0,
129.1, 128.9, 127.6, 127.5, 127.5, 127.1, 127.1, 126.8, 123.5, 123.4,
52.5, 49.2, 35.4, 33.4, 21.7, 21.3 ppm. HRMS (ESITOF) m/z: [M +
H]+ calcd for C12H15BrNO, 268.0332; found, 268.0332.
(E)-1-methyl-5-styrylpyrrolidin-2-one (3ab)9 was obtained as
colorless oil (33.0 mg, 82%); purification by silica gel chromatography
1
(Rf = 0.18 eluent: PE/EA = 1:1); H NMR (400 MHz, CDCl3-d): δ
7.42−7.25 (m, 5H), 6.56 (d, J = 15.8 Hz, 1H), 6.01 (dd, J = 15.8, 8.6
Hz, 1H), 4.14−4.02 (m, 1H), 2.78 (s, 3H), 2.55−2.24 (m, 3H),
1.89−1.77 (m, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3-d): δ
175.1, 135.9, 133.0, 128.9, 128.7, 128.2, 126.5, 63.0, 30.0, 27.9, 25.7
ppm.
(E)-5-(4-chlorostyryl)-1-methylpyrrolidin-2-one (3bb) was ob-
tained as pale-yellow oil (38.2 mg, 81%); purification by silica gel
1
chromatography (Rf = 0.13 eluent: PE/EA = 1:1); H NMR (400
MHz, CDCl3-d): δ 7.28 (d, J = 12.4 Hz, 4H), 6.51 (d, J = 15.8 Hz,
1H), 5.99 (dd, J = 15.8, 8.5 Hz, 1H), 4.14−4.02 (m, 1H), 2.77 (s,
3H), 2.54−2.23 (m, 3H), 1.87−1.76 (m, 1H) ppm; 13C{1H} NMR
(100 MHz, CDCl3-d): δ 175.0, 134.3, 133.8, 131.7, 129.5, 128.8,
127.7, 62.8, 29.9, 27.9, 25.6 ppm. HRMS (ESITOF) m/z: [M + H]+
calcd for C13H15ClNO, 236.0837; found, 236.0840.
(E)-N-(3-(2-fluorophenyl)allyl)-N-methylacetamide (3ia) was ob-
tained as pale-yellow oil (34.4 mg, 83%); purification by silica gel
1
chromatography (Rf = 0.21 eluent: PE/EA = 1:1); H NMR (400
MHz, CDCl3-d): δ 7.41 (q, J = 7.2, 6.8 Hz, 1H), 7.18 (d, J = 11.8 Hz,
1H), 7.13−6.98 (m, 2H), 6.61 (t, J = 14.8 Hz, 1H), 6.27−6.14 (m,
1H), 4.15 (d, J = 6.4 Hz, 2H), 4.06 (d, J = 5.2 Hz, 1H), 2.98 (s,
1.6H), 2.97 (s, 1.4H), 2.13 (s, 1.4H), 2.12 (s, 1.6H) ppm; 13C{1H}
NMR (100 MHz, CDCl3-d): δ 170.7, 170.5, 161.3, 158.8, 129.2 (d, J
= 8.5 Hz), 128.9 (d, J = 8.5 Hz), 127.6 (d, J = 3.6 Hz), 127.3 (d, J =
3.6 Hz), 127.2 (d, J = 4.6 Hz), 126.5 (d, J = 5.4 Hz), 124.9 (d, J = 3.8
Hz), 124.6, 124.3, 124.1 (d, J = 3.6 Hz), 124.0 (d, J = 3.5 Hz), 115.9,
115.7, 115.7, 115.5, 52.8, 49.5, 35.5, 33.4, 21.7, 21.3 ppm. HRMS
(ESITOF) m/z: [M + H]+ calcd for C12H15FNO, 208.1132; found,
208.1132.
(E)-5-(4-bromostyryl)-1-methylpyrrolidin-2-one (3cb) was ob-
tained as pale-yellow oil (44.8 mg, 80%); purification by silica gel
1
chromatography (Rf = 0.13 eluent: PE/EA = 1:1); H NMR (400
MHz, CDCl3-d): δ 7.45 (d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.4 Hz, 2H),
6.49 (d, J = 15.8 Hz, 1H), 6.01 (dd, J = 15.8, 8.4 Hz, 1H), 4.16−3.97
(m, 1H), 2.77 (s, 3H), 2.53−2.24 (m, 3H), 1.91−1.75 (m, 1H) ppm;
13C{1H} NMR (100 MHz, CDCl3-d): δ 175.0, 134.8, 131.8), 131.7,
129.7, 128.0, 122.0, 62.8, 29.9, 28.0, 25.6 ppm. HRMS (ESITOF) m/
z: [M + H]+ calcd for C13H15BrNO, 280.0332; found, 280.0333.
(E)-5-(4-fluorostyryl)-1-methylpyrrolidin-2-one (3db) was ob-
tained as pale-yellow oil (36.8 mg, 84%); purification by silica gel
(E)-N-(3-(2-methoxyphenyl)allyl)-N-methylacetamide (3ja)9 was
obtained as pale-yellow oil (30.7 mg, 70%); purification by silica gel
1
chromatography (Rf = 0.15 eluent: PE/EA = 1:1); H NMR (400
1
chromatography (Rf = 0.22 eluent: PE/EA = 1:1); H NMR (400
MHz, CDCl3-d): δ 7.37−7.33 (m, 2H), 7.01 (t, J = 8.8 Hz, 2H), 6.52
(d, J = 15.8 Hz, 1H), 5.92 (dd, J = 15.8, 8.4 Hz, 1H), 4.12−4.02 (m,
1H), 2.77 (s, 3H), 2.51−2.24 (m, 3H), 1.88−1.77 (m, 1H) ppm;
13C{1H} NMR (100 MHz, CDCl3-d): δ 175.0, 163.8, 161.3, 132.0,
131.7, 128.6 (d, J = 2.2 Hz), 128.1 (d, J = 8.1 Hz), 115.6 (d, J = 21.6
Hz), 62.8, 29.9, 27.9, 25.7 ppm. HRMS (ESITOF) m/z: [M + H]+
calcd for C13H15FNO, 220.1132; found, 220.1131.
(E)-4-(2-(1-methyl-5-oxopyrrolidin-2-yl)vinyl)benzonitrile (3eb)
was obtained as a pale-yellow solid (37.1 mg, 82%); mp 88−91 °C;
purification by silica gel chromatography (Rf = 0.14 eluent: PE/EA =
1:3); 1H NMR (400 MHz, CDCl3-d): δ 7.58 (d, J = 8.0 Hz, 2H), 7.44
(d, J = 8.4 Hz, 2H), 6.54 (d, J = 15.8 Hz, 1H), 6.15 (dd, J = 15.8, 8.4
Hz, 1H), 4.15−4.07 (m, 1H), 2.76−2.74 (m, 3H), 2.48−2.24 (m,
3H), 1.87−1.75 (m, 1H) ppm; 13C{1H} NMR (100 MHz, CDCl3-d):
δ 174.9, 140.2, 132.8, 132.4, 131.0, 126.9, 118.6, 111.2, 62.4, 29.6,
27.9, 25.3 ppm. HRMS (ESITOF) m/z: [M + H]+ calcd for
C14H15N2O, 227.1179; found, 227.1180.
(E)-5-(4-methoxystyryl)-1-methylpyrrolidin-2-one (3fb) was ob-
tained as a pale-yellow solid (35.2 mg, 76%); mp 56−59 °C;
purification by silica gel chromatography (Rf = 0.13 eluent: PE/EA =
1:1) 1H NMR (400 MHz, CDCl3-d): δ 7.30 (d, J = 8.8 Hz, 2H), 6.85
(d, J = 8.8 Hz, 2H), 6.49 (d, J = 15.6 Hz, 1H), 5.84 (dd, J = 15.6, 8.6
Hz, 1H), 4.07−3.99 (m, 1H), 3.79 (d, J = 1.2 Hz, 3H), 2.75 (s, 3H),
2.48−2.23 (m, 3H), 1.87−1.73 (m, 1H) ppm; 13C{1H} NMR (100
MHz, CDCl3-d): δ 175.0, 159.5, 132.4, 128.6, 127.7, 126.5, 114.0,
63.0, 55.2, 30.0, 27.8, 25.8 ppm. HMSR (ESITOF) m/z: [M + H]+
calcd for C14H18NO2, 232.1332; found, 232.1321.
MHz, CDCl3-d): δ 7.41 (d, J = 7.8 Hz, 1H), 7.26−7.17 (m, 1H),
6.99−6.82 (m, 2H), 6.81 (dd, J = 16.0, 12.4 Hz, 1H), 6.19−6.08 (m,
1H), 4.18−4.12 (m, 1H), 4.08−4.02 (m, 1H), 3.84 (d, J = 1.6 Hz,
3H), 2.97 (d, J = 2.0 Hz, 3H), 2.13 (d, J = 10.8 Hz, 3H) ppm;
13C{1H} NMR (100 MHz, CDCl3-d): δ 170.7, 170.4, 156.7, 156.5,
129.0, 128.7, 127.7, 127.1, 127.0, 126.8, 125.5, 125.1, 125.0, 124.2,
120.6, 110.8, 110.8, 55.4, 55.4, 53.1, 49.6, 35.3, 33.3, 21.8, 21.3 ppm.
(E)-N-methyl-N-(3-(p-tolyl)allyl)acetamide (3ka)9 was obtained
as colorless oil (31.3 mg, 77%); purification by silica gel
1
chromatography (Rf = 0.22 eluent: PE/EA = 1:1); H NMR (400
MHz, CDCl3-d): δ 7.29−7.23 (m, 2H), 7.12 (t, J = 8.2 Hz, 2H), 6.44
(dd, J = 15.8, 10.8 Hz, 1H), 6.13−6.03 (m, 1H), 4.13 (d, J = 6.4 Hz,
1H), 4.04 (d, J = 5.2 Hz, 1H), 2.97 (s, 3H), 2.34 (s, 1.6H), 2.33 (s,
1.4H), 2.14 (s, 1.5H), 2.12 (s, 1.5H) ppm; 13C{1H} NMR (100 MHz,
CDCl3-d): δ 170.8, 170.4, 137.8, 137.5, 133.7, 133.2, 132.7), 131.6,
129.3, 129.2, 126.2, 126.2, 123.4, 122.5, 52.6, 49.2, 35.3, 33.4, 21.8,
21.3, 21.1 ppm.
(E)-N-(3-(3-cyanophenyl)allyl)-N-methylacetamide (3ma) was
obtained as pale-yellow oil (35.1 mg, 82%); purification by silica gel
1
chromatography (Rf = 0.22 eluent: PE/EA = 1:3); H NMR (400
MHz, CDCl3-d): δ 7.62−7.37 (m, 4H), 6.43 (dd, J = 16.0, 4.0 Hz,
1H), 6.26−6.14 (m, 1H), 4.16−4.13 (m, 1H), 4.10−4.07 (m, 1H),
2.99 (s, 1.8H), 2.96 (s, 1.2H), 2.12 (s, 1.8H), 2.11 (s, 1.2H) ppm;
13C{1H} NMR (100 MHz, CDCl3-d): δ 170.7, 170.6, 137.7, 137.3,
131.1, 130.8, 130.5, 130.4, 130.1, 129.8, 129.7, 129.5, 129.3, 129.3,
127.5, 126.8, 118.6, 118.5, 112.8, 112.6, 52.3, 49.1, 35.7, 33.5, 21.7,
3994
J. Org. Chem. 2021, 86, 3989−3998